AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-733 Cr | ₹-1,051 Cr | ₹-108 Cr | ₹-460 Cr | ₹-318 Cr |
What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-733 Cr |
| Mar2024 | ₹-1,051 Cr |
| Mar2023 | ₹-108 Cr |
| Mar2022 | ₹-460 Cr |
| Mar2021 | ₹-318 Cr |
How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-733 Cr | Negative | |
| Mar2024 | ₹-1,051 Cr | Negative | |
| Mar2023 | ₹-108 Cr | Negative | |
| Mar2022 | ₹-460 Cr | Negative | |
| Mar2021 | ₹-318 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹39,085.6 Cr | 5.4% | 0.2% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 5.4% |
0.2% |
22.2% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses